Trials / Recruiting
RecruitingNCT04885374
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Dongzhimen Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).
Detailed description
The CARE-TCM is a prospective, multi-center, patient registry study. Eligible ALS patients with TCM treatments will be enrolled in the registry. After enrollment, this research collects the individual characteristics of patients' status. Longitudinal follow-up data are collected from both patients (primary caregivers) and their treating neurologists every 3 months for 5 years. The aims of the CARE-TCM are to: 1) explore the general characteristics of ALS patients with TCM and; 2) assess the effectiveness and safety of various TCMs on ALS based on nationwide registry outcome collecting process.
Conditions
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2027-05-01
- Completion
- 2028-03-01
- First posted
- 2021-05-13
- Last updated
- 2021-05-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04885374. Inclusion in this directory is not an endorsement.